Evidence map›Paper›PMID 39729202›Full record

SynthesisNeurosurgical review2024

Prevalence and risk factors of sarcopenia in patients with stroke: a systematic review and meta-analysis.

Xiang He, Xiping Shen, Tingting Yang, Guifen Ma, Jinhan Nan, Juanjuan Feng, Fanghong Yan, Cuilian Wang, Lin Han, Yanan Zhang and 1 more

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Neurosurgical review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiang He *Evidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China.
Xiping Shen *School of Public Health, Lanzhou University, Lanzhou, 730010, Gansu Province, China.
Tingting YangEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China.
Guifen MaDepartment of Nursing, Gansu Provincial Hospital, Lanzhou, 730030, Gansu Province, China.
Jinhan NanEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China.
Juanjuan FengEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China.
Fanghong YanEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China.
Cuilian WangThe Second Hospital of Lanzhou University, Lanzhou, 730030, Gansu Province, China.
Lin HanEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China.
Yanan ZhangEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China. zhangyanan@lzu.edu.cn.
Yuxia MaEvidence-Based Nursing-Center, School of Nursing, Lanzhou University, 730010, No.28, West Yan Road, Chengguan District, Lanzhou, Gansu Province, China. yuxiama@lzu.edu.cn.

Funding

Chengguan District Science and Technology Bureau of Lanzhou 2022SHFZ0002Fundamental Research Funds for the Central Universities lzujbky-2024-ou12Key Research and Development Program of Gansu Province 23YFFA0006National Natural Science Foundation of China 72474092Nature Science Foundation of Gansu Province 22JR5RA218
6 · The paper itself

Abstract

Stroke is the second leading cause of death and the third-leading cause of disability in the world. The skeletal muscles play a key role in disability following stroke. Although many studies have reported the prevalence and risk factors of sarcopenia in patients with stroke, the results have not been synthesized. This systematic review was conducted to explore the prevalence and risk factors of sarcopenia in patients with stroke. PubMed, Embase, The Cochrane Library, Web of Science, Chinese Biomedical Literature (CBM), China National Knowledge Infrastructure (CNKI), Weipu Database (VIP), Wanfang Database were comprehensively searched for studies exploring the prevalence and risk factors of sarcopenia in patients with stroke from inception to October 5th, 2022. This review included 19 studies involving 4148 subjects. The total prevalence of sarcopenia in patients with stroke is 46% (95% confidence interval, CI: 40% to 52%, I

Indexed as

SarcopeniaStrokeHumansPrevalenceRisk FactorsMeta-analysisPrevalenceRisk factorsSarcopeniaStroke

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.